RAPM Impact Factor Reaches 7.015
Clarivate Analytics announced that the 2019 Impact Factor (IF) for Regional Anesthesia and Pain Medicine (RAPM) is 7.015, placing it 2nd out of the 32 journals listed by Clarivate in the anesthesiology category.
After rising by 0.7 points between 2017 and 2018, RAPM's IF increased by nearly 2 points between 2018 and 2019.
IF is a measure of the frequency that articles within the journal are cited in other journals. It is just one of the many metrics that are used to measure journal performance.
Read more about the journal's top-cited articles of the last two years, as well as several additional metrics that illustrate the journal's performance, including its CiteScore, SciMago Journal Rank, and Eigenfactor. To celebrate the IF, these articles have been made free to read by all.
“This exceptional performance strongly attests to the efforts of ASRA and the journal's editorial board in building RAPM into a leading resource for anesthesiologists around the world,” said Editor-in-Chief Brian D. Sites, MD.
RAPM is the official journal of ASRA. Published monthly, access to the journal is provided as a benefit of membership in ASRA. Coverage includes intraoperative regional techniques, perioperative pain, chronic pain, obstetric anesthesia, pediatric anesthesia, outcome studies, and complications. Learn more about the journal's impressive editorial board here.
In its 45th year, RAPM is also the official publication of the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the Asian and Oceanic Society of Regional Anesthesia (AOSRA), the Latin American Society of Regional Anesthesia (LASRA), and the African Society for Regional Anesthesia (AFSRA).